45
Templar Nova raises $7M in first capital round for biotech venture
Company raise · Closed · ROCKVILLE, MD · Form D filed 2026-10-07
Templar Nova, a Delaware corporation incorporated in 2026, raised $7M in a closed offering under Regulation D exemption 6(b) from two investors. The Rockville, Maryland-based biotechnology company completed its first sale on September 28, 2026.
Note: Company incorporated in 2026 and filed Form D in October 2026; this is the issuer's first appearance on EDGAR. Minimum investment equals total offering ($7M), suggesting a single institutional investor or syndicate treated as one investor line.
First raise on EDGARoperating_company
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
People on the filing
| Xi Steven Chen | General Counsel |
Signed by Xi Chen, General Counsel.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.